Understanding how IDO2 affects immune responses in autoimmune diseases
Defining the cellular and molecular mechanism of IDO2 function driving autoimmune vs.protective immune responses
This study is looking at how a specific enzyme called IDO2 in immune cells might be causing problems in autoimmune diseases like arthritis, and it aims to find new ways to help people with these conditions feel better without the harsh side effects of current treatments.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Lankenau Institute for Medical Research NIH-funded |
| Lab location | 1 site (Wynnewood, United States) |
| Project ID | NIH-11044418 on NIH RePORTER |
What this research studies
This research investigates the role of IDO2, an enzyme found in immune cells, in driving autoimmune responses that lead to diseases like arthritis. By using genetic and pharmacological methods in a specific model of inflammatory arthritis, the researchers aim to uncover how IDO2 contributes to the production of autoantibodies and inflammation. The study also explores a novel function of IDO2 that may influence immune cell behavior, particularly in B cells. The goal is to identify new therapeutic targets that could alleviate symptoms of autoimmune diseases without the severe side effects associated with current treatments.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from autoimmune diseases, particularly those with inflammatory arthritis.
Not a fit: Patients with autoimmune diseases that do not involve B cell activation or those who do not respond to current treatments may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments for autoimmune diseases that reduce inflammation and improve patient quality of life.
How similar studies have performed: Previous research has shown promise in targeting immune pathways for autoimmune diseases, but the specific role of IDO2 is still being explored, making this a novel investigation.
Where this research is happening
Wynnewood, United States
- Lankenau Institute for Medical Research — Wynnewood, United States (Active)
Researchers
- Principal investigator: Mandik-Nayak, Laura — Lankenau Institute for Medical Research
- Study coordinator: Mandik-Nayak, Laura
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.